Lipoprotein(a)

New guidelines and consensus this year

1. A Synopsis of the 2025 U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guideline for Lipid Management for Cardiovascular Disease Risk Reduction
   Ann Intern Med2026 Sep 15
2. Lipoprotein(a) in Japan: An Expert Consensus Statement
   J Atheroscler Thromb2026 Sep 14
3. [Dyslipidaemia guideline issued by the Department of Internal Medicine (DIM) at the University Hospital Zurich (USZ)]
   Praxis (Bern 1994)2026 Aug
4. Lipid clinics worldwide: harmonization and guidance on how to optimally organize and fund. European Atherosclerosis Society consensus statement across 55 countries and more than 500 lipid clinics
   Atherosclerosis2026 Jul
5. 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
   J Am Coll Cardiol2026 May 19

1. Longitudinal automated lipid target monitoring integrated into a laboratory-based clinical decision support system: a real-world cardiovascular risk management approach
   Clin Chim Acta2027 Feb 15PMID 42603582
2. Lipoprotein(a) and early LDL-cholesterol target attainment after a first acute coronary syndrome: a real-world cohort study
   Atheroscler Plus2026 DecPMID 42876442
3. Identifying and resolving analytical outliers in lipoprotein(a) immunoassay testing
   Pract Lab Med2026 DecPMID 42871872
4. Lipoprotein(a)-dependent cardiovascular risk in different populations: are thresholds the same?
   Ann Med2026 DecPMID 42856082Review
5. Passive E06 IgG reduces lesional PC-OxPL and macrophage accumulation in cholesterol-fed Ldlr(-/-) mice
   Atheroscler Plus2026 DecPMID 42840725
6. Early-onset atherosclerotic cardiovascular disease in young adults: Lifestyle, environmental, and psychosocial risk factors
   Int J Cardiol Cardiovasc Risk Prev2026 DecPMID 42835958Review
7. Effects of PCSK9 inhibitors on coronary atheroma morphology in patients with coronary artery disease treated with statins: a meta-analysis and systematic review
   Am J Prev Cardiol2026 DecPMID 42827838
8. Lower lipoprotein(a) levels in patients with acute lacunar infarction
   IBRO Neurosci Rep2026 DecPMID 42774994
9. Comment on "Lipoprotein(a) reduction with inclisiran, alirocumab, evolocumab, enlicitide, and lerodalcibep: A systematic review and meta-analysis of randomized controlled trials"
   Int J Cardiol Cardiovasc Risk Prev2026 DecPMID 42774982
10. Association between serum lipoprotein(a) levels and aortic vulnerable plaques assessed by non-obstructive general angioscopy
    Atheroscler Plus2026 DecPMID 42774604